89results about How to "Lower postprandial blood sugar" patented technology

The invention relates to a pharmaceutical composition having alpha-glucosidase inhibition activity, wherein the pharmaceutical composition comprises a flavone compound and an alpha-glucosidase inhibitor, the flavone compound is at least one selected from a monomer such as baicalein, quercetin, luteolin, baicalein-7-O-glucoside and catechin, an organic salt of the monomer, and an inorganic salt of the monomer, and the alpha-glucosidase inhibitor is at least one selected from a monomer such as acarbose, voglibose and miglitol, an organic salt of the monomer, and an inorganic salt of the monomer. According to the present invention, the pharmaceutical composition can effectively reduce postprandial blood glucose, can inhibit the activity of alpha-glucosidase adopting starch, maltose and sucrose as substrates, and less uses the alpha-glucosidase inhibitor, such that the efficacy can be improved, the side effect of the alpha-glucosidase inhibitor can be effectively reduced, and hypoglycemia and other problems easily caused by drug combination are effectively solved.

The invention belongs to the field of health food, and relates to a composition for dropping after meal blood sugar and application thereof. The composition is prepared from, by weight, 5-60% of oat bran powder, 1-8% of white kidney bean extract, 1-8% of potato extract, 1-8% of pueraria extract, and 5-65% of dietary fiber; wherein, the percentage weighted sum of the components is 100%. The oat bran powder, white kidney bean extract, potato extract, pueraria extract, and dietary fiber are used as functional materials for preparing the composition with the effect of dropping after meal blood sugar; the five components are scientifically combined, act in coordination, can be prepared into oral medicines for effectively dropping after meal blood sugar though the rational collocations with supplementary food materials. The composition improves the medicinal adaptability of diabetes patients, and alleviates the sufferings from medicine taking.

The invention provides a wolfberry polygonatum coffee, which is characterized in that it consists of the following components in mass ratio: 1-5% wolfberry extract, 1-5% polygonatum extract, 7-15% coffee, and 5-5% xylitol 20%, the balance of non-dairy creamer. It not only has the unique flavor and aroma of coffee, but also promotes blood circulation, excites nerves, eliminates fatigue, improves indigestion, etc., and also makes coffee drinks have the effect of assisting in lowering blood sugar and consolidating the effect of lowering blood sugar. Drinking the wolfberry polygonatum coffee of the present invention can make the active ingredients in the wolfberry extract and polygonatum odoratum extract be absorbed by the human body rapidly together with the coffee components, and produce the effect of lowering blood sugar and consolidating the effect of lowering blood sugar, which is beneficial to health.

The invention discloses a production method of nutrition powder capable of reducing after-dinner blood sugar of diabetes patients, comprising the following steps of: fully soaking raw materials rich in starch in the water, and heating and cooking to obtain aging powder; emulsifying tea seed oil or other plant oil, 5-60 percent by weight of the aging powder and nutrient needing intensification, and mixing the emulsified product with the balance of the aging powder to obtain the nutrition powder. The nutrition powder capable of reducing after-dinner blood sugar of diabetes patients which is produced by using the method of the invention can completely replace the diet for the diabetes patients. The food not only can ensure the nutrition requirement of the diabetes patients, but also can control the after-dinner blood sugar, thereby having a certain auxiliary function of treating and recovering the diabetes patients.

The invention belongs to the technical field of foods, in particular to a minor cereal porridge can which contains fructo-oligosaccharide (FOS) and tomato paste. The minor cereal porridge can is formed by sealing a metal can or a plastic cup filled with a minor cereal porridge food, wherein the minor cereal porridge food is mainly prepared from the following components in parts by weight: 3-15 parts of FOS, 1-9 parts of tomato paste, 76-93 parts of water, 0-1 part of konjaku flour, 30-70 parts of bean and 30-70 parts of minor cereals, wherein the bean is one or more of kidney bean, garden peaand green soybean; and the minor cereal is one or more of shelled corn, shelled oat, rice, barley and wheat kernel and rice kernel. In the invention, porridge is prepared by making soup in a way of diluting FOS and tomato paste with water, mixing the soup with minor cereals and curing, so that a fully natural food which keeps a natural color and does not contain any chemical additive is obtained,and the defects of monotonous mouthfeel, small quantity of soybean cereals and large quantity of food additives existing in the conventional eight-treasure porridge food are overcome.

The invention provides application of neohesperidin in preparing of diabetes preventive treatment compound medicines or health care products. Neohesperidin is extracted and separated from citrus grape fruit tengyuch euonymus bark layers and is subjected to glucose and lipid metabolism biological activity research, and just as naringin, neohesperidin can obviously increase hepatic cell glucose consumption, improve phosphorylation levels of glucose and lipid metabolism related protein adenosine monophosphate activated protein kinase (AMPK) and lipid synthesized key protein activated calcium carbonate (ACC) and cooperate to reduce triglyceride level in lipopexia hepatic cells molded by free fatty acid, has effects of prompting reduction of blood sugar and blood lipid levels, and effect concentration of neohesperidin is far lower than that of positive medicine metformin. Neohesperidin can serve as ancillary drugs or health care products to be used for preventive treatment of diseases related to glucose and lipid metabolism disorder.

The invention relates to application of total saponins in unripe siraitia grosvenorii fruit extract in preparation of an assistant hypoglycemic drug. Extract containing the total saponins with the content by weight of 60%-90% is extracted from unripe siraitia grosvenorii fruit with the growing period of 30 days-80 days, one of the effective ingredients mogroside II and mogroside III in the total saponins or a mixture of the effective ingredients mogroside II and mogroside III in the total saponins inhibits the activity of alpha-glucosidase in vitro and in vivo, the fasting blood-glucose level and the postprandial blood glucose level of a type-II diabetic mouse are lowered, and the activity of the insulin resistance index is reduced; in addition, new application of the total saponins in preparation of food or the drug for assisting in treating insulin resistance and type-II diabetes mellitus is achieved.

The invention relates to a health staple food capable of reducing postprandial blood sugar, and also relates to a preparation method of the health staple food and its application in reducing blood sugar. The health staple food with a low glycemic index comprises, by weight, 51-61% of rice, 16-26% of peanut kernel, and 18-28% of peeled mung bean. With organic food as the raw material, the health staple food of the invention is totally prepared with a physical processing method, without any harmful components added. No natural nutritious component in the raw material can be damaged. As a pollution-free green food, the health staple food of the invention integrates nutrition, diseases prevention and disease curing, thus ushering in the application prospect of coarse cereal food. And the application value of coarse cereals is enhanced, with remarkable economic benefit and social benefit. With a low glycemic index, the integrated staple food provided in the invention plays a role in reducing postprandial blood sugar, reducing glycated hemoglobin, and has certain effect on fat-reducing, thus being significant to diabetic patients.

The invention discloses a pharmaceutical composition or health care product having a blood sugar reduction effect. The pharmaceutical composition contains the following components in parts by weight: 260-520 parts of momordica charantia extract, 290-600 parts of olive extract, 230-540 parts of cinnamon extract, 150-280 parts of guava extract, 140-310 parts of tartary buckwheat extract, 20-80 parts of astaxanthin, 20-40 parts of lutein, 10-25 parts of chromium-containing yeast, and 2500-3800 parts of xylitol. After being added with auxiliary materials or carries required for preparation forming, the pharmaceutical composition disclosed by the invention can be prepared into any suitable pharmaceutical preparation acceptable clinically according to a conventional preparation method in the field. Proved by pharmacology test result, the pharmaceutical composition or health care product has good effect of reducing blood sugar, has no toxic or side effect on animals, and is safe to take.

The invention provides application and blood-sugar lowering effective part of trapa acornis nakano shell as well as an extraction method of the blood-sugar lowering effective part, belonging to the technical field of traditional Chinese medicine. The new application of the trapa acornis nakano shell is to prepare a blood-sugar lowering medicine. The blood-sugar lowering effective part of the trapa acornis nakano shell is selected from one or any composite of petroleum ether part (TAPE), ethyl acetate part (TAEA) and n-butyl alcohol part (TABU) of the alcohol extract of trapa acornis nakano shell. The extraction method of the effective part comprises the following steps: grinding the dried trapa acornis nakano shell, carrying out digestion on the trapa acornis nakano shell powder with the aqueous solution of methyl alcohol or ethanol, and concentrating the immersion liquid to obtain extract; extracting the extract with petroleum ether, ethyl acetate or n-butyl alcohol for three times respectively; and volatilizing the dissolvent to obtain the TAPE, the TAEA or the TABU of the trapa acornis Nakai shell. Each effective part has good activity in inhibiting alpha-glucuroide. In vitro tests prove that TAEA and TABU have relatively good therapeutic effect on mice suffering from diabetic induced by mesoxyalyurea.

The invention discloses sericin peptide with alpha-glycosidase inhibiting activity. The sequence of the sericin peptide is as shown in SEQ ID No: 1. The invention further relates to a synthesis preparation method of the sericin peptide with the alpha-glycosidase inhibiting activity and the application of biological activity of the sericin peptide. The sericin peptide disclosed by the invention has an important significance on food development, a health care product and a medicine which are capable of reducing postprandial blood sugar and development of food, a health care product and a medicine which are used for treating type 2 diabetic mellitus.

The invention discloses flour having functions of reducing blood sugar and reducing weight and capable of being made into dough through fermentation, and relates to the technical field of foods. The flour consists of the following components in percentage by weight of 50-70% of a powder filler, 20-50% of gluten flour, and 0-10% of seasoning powder, wherein the powder filler is prepared by mixing one or more of almond kernel powder, linseed meal, chia seed powder, chickpea powder, coconut powder, sunflower seed powder, pumpkin seed powder, soybean flour, walnut meat powder, wheat bran powder, psyllium husk powder, pea protein powder or whey protein powder in any proportion; the gluten flour is prepared by mixing the vital wheat gluten with one or more of the pea protein powder, the whey protein powder, the soybean protein powder or the psyllium husk powder; and the seasoning powder is prepared by mixing the whey protein powder with the walnut meat powder, cooked soybean flour and the soybean protein powder. The flour disclosed by the invention can effectively reduce the blood sugar of patients suffering from non-insulin dependent diabetes and has the efficacy of reducing weight.

The invention discloses a medicine-food dual-purpose composition for reducing postprandial blood sugar (IGT state) and a preparation method, and belongs to the field of preparing food-therapy products, healthcare products and traditional Chinese medicines. The medicine-food dual-purpose composition is prepared from the following components in parts by weight: 12-25 parts of extract of leaf of narrow-leaved oleaster, 15-28 parts of mongolian dandelion herb extract, 9-16 parts of mulberry leaf extract, 5-9 parts of longstamen onion bulb extract and 35-50 parts of chicory herb extract. The preparation method of the composition comprises the following steps: performing low-temperature extracting, low-temperature concentration and low-temperature drying on the leaf of narrow-leaved oleaster, mongolian dandelion herb, the mulberry leaves, the longstamen onion bulb and the chicory herb, and then preparing the extracts into various oral preparations. According to the medicine-food dual-purpose composition for reducing postprandial blood sugar (IGT state) and the preparation method, the components are medicine-food dual-purpose species, so that the composition is safe and can be taken for a long time; the medicine-food dual-purpose composition can effectively reduce the postprandial blood sugar (IGT state), and is a safe and effective product for prediabetic-state patients; the medicine-food dual-purpose composition can also exert an intervention effect on the diabetic patients.

The diabetes treating medicine has polymethyl galacturonate compound as effective component. When water solution of the polymethyl galacturonate compound is taken by diabetics while starch food is tanken, water solution of the polymethyl galacturonate compound and the starch food are mixed inside stomach to form gel under the action of gastric acid. The gel increases the adhesion of matter inside small intestine and forms one glue layer to lower the diffusion speed of starch formed glucose to intestinal mucosa cell and to delay and inhibit the absorption of small intestine to glucose, so as to lower the peak value of postprandial blood sugar. The macro molecular polymethyl galacturonate incapable of penetrating gastrointestinal tract barrier is ultimately excreted to outside body completely without being digested and absorbed.

The invention aims at providing a low-sugar high-calcium medical granule and a production process. The low-sugar high-calcium granule includes zymolytic cattle bone powder, tuckahoe extract, milk protein, oligosaccharides, pumpkin powder, casein phosphoric peptide, vitamin and minerals. The absorptivity of the granule calcium is notably improved compared with the equivalent products, is in particular applicable for the diabetes sufferers to take for long time. The production process crushes and mixes the zymolytic cattle bone powder and the tuckahoe extract completely, so that the grease and the phlegm working against crushing in the mixture can be fully absorbed, and airflow ultramicro crushing technical process is available for obtaining calcium-source fine powder, the technical process is stable and is suitable for scaled industry production.

The invention relates to a processing method of wheat germ steamed buns. The making method comprises the following steps of step 1, making mixed lactobacillus powder; step 2, making a mixed lactobacillus solution; step 3, performing kneading to obtain sour dough; step 4, performing fermentation; and step 5, making the steamed buns. According to the scheme of the making method disclosed by the invention, various bacteria species of lactobacillus bulgaricus, streptococcus thermophilus, lactobacillus acidophilus, lactobacillus plantarum, bifidobacteria, lactobacillus rhamnosus and the like are adopted to perform mixed fermentation to make the sour dough; the bacterial strains are coordinated for fermentation, so that the flavor of the steamed bus can be improved, the effects of resisting bacteria and prolonging the quality guarantee period are achieved, and the steamed buns have good anti-aging product; the wheat germ steamed buns obtained by the making method disclosed by the invention are high in nutrient value, and contain rich vitamin E, vitamin B1 and protein; and wheat germs also contain various minerals and various trace elements of calcium, potassium, magnesium, ferrum, zinc,chromium, selenium, phosphorus, manganese, copper and the like.

The invention relates to a pharmaceutical composition for treating impaired glucose regulation and a preparation method thereof. The pharmaceutical composition is mainly composed of a bitter gourd extract, a polygonatum odoratum extract, a mulberry leaf extract, a pseudo-ginseng extract, a cinnamomum cassia presl extract and chromium picolinate, and is a medicament prepared by adopting a pharmaceutically acceptable carrier or excipient, wherein the medicament includes capsules, granules, tablets, pills and the like. The pharmaceutical composition has the efficacies of supplementing qi, nourishing yin, clearing heat and activating blood, and is suitable for patients with impaired glucose regulation and early-stage and mild diabetes to take. Clinical studies show that the pharmaceutical composition can reduce fasting blood-glucose and postprandial blood glucose and has no toxic or side effect.

The invention discloses a Chinese herbal compound functional food for adjuvant therapy of diabetes and a preparation method thereof. The Chinese herbal compound functional food consists of the following raw materials: a burdock root extract, a pueraria extract, a rhizoma polygonati extract, vitamin C, xylooligosaccharide, xylitol, an arabian jasmine flower extract and magnesium stearate. Accordingto the Chinese herbal compound functional food for adjuvant therapy of diabetes, the postprandial blood sugar and fasting blood-glucose can be reduced effectively, the food can be used for adjuvant therapy of diabetics, the food is reasonable in formula and high in safety and has prevention and treatment effects for diabetic complications, the kidney injury degree of diabetics can be improved, the life cycle of diabetics is prolonged, and the life quality of diabetics is improved; the Chinese herbal compound functional food for adjuvant therapy of diabetes disclosed by the invention is rich in hypoglycemic activity substances such as fructo-oligosaccharides, polysaccharides, anthraquinone compounds and various amino acids and vitamins, is sour and sweet and unique in flavor, and has the functions of health care and nutrition.

The invention belongs to the field of functional food preparation, and particularly relates to a protein-type solid beverage with fat reduction and body shaping effects. The solid beverage comprises the following raw materials: whey protein, soybean protein isolate, white kidney beans, green coffee powder, milk mineral salts, dietary fibers, polydextrose, chia seeds, psyllium seed husk powder, a potato extract and citrus fibers. The solid beverage provided by the invention has the effects of reducing fat and slimming, is rich in nutrient components such as vitamins, proteins and the like, is rich in nutrition, and can well exert a meal replacing effect. The preparation method is simple, and is easy for industrial production and popularization and application.

The invention relates to dietary fabric compositions containing konjac glucomannan and their preparing process, wherein the compositions can be made into capsules or chewing tablets, and comprise konjac glucomannan 30-90 wt%, acacia gum 5-60 wt%, laminaria powder 5-10 wt%, green tea powder 1-10 wt%, and conventional food additives, such as 0-20 wt% of microcrystalline cellulose.